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Dexpramipexole effect on Allodynia in Female Rats

Introduction
• Neuropathic pain can be described as the damage caused to the somatosensory
system manifested as an increase in sensitivity to light choice, clinically referred to
as allodynia.
• Prenatal alcohol exposure is a risk factor for developing allodynia via enhanced
neuroimmune, proinflammatory actions in the central nervous system (CNS) such
as the spinal cord.
• Neuropathic pain is mediated by cytokines secreted from infiltrating peripheral
immune cells to CNS and glial cells that reside within the CNS.
• Interelukin-10 (IL-10) is a potent anti-inflammatory cytokine that inhibits the
production of a variety proinflammatory cytokines and chemokines released by
different types of immune cells such as T helper (Th1) and natural killer (NK) cells,
and macrophages, which prevent further tissue damage.
• Interferon-γ (IFNγ) is a soluble cytokine that serves as a T cell and macrophage
activator in response to inflammation and can further enhance inflammatory
processes.
• While pramipexole serves as a dopamine receptor agonist (D2/D3 receptors) used
to reduce progressive movement disorders observed in Parkinson’s disease,
dexpramipexole [(+)-pramipexole] is an enantiomer of (-)-pramipexole and has very
weak actions at the D2/D3 receptors. However, dexpramipexole reduces caspase-3
activation, and decreases cell death, suggesting that this compound may play a
role in anti-inflammatory processes.
• Prior unpublished data from our lab show that an i.v. injection of dexpramipexole
reverses ongoing allodynia in non-PAE mice.
• Further unpublished work from our lab revealed intrathecal (i.t.; subarachnoid,
surrounding the spinal cord) dexpramapixole reverses chronic allodynia in PAE
male rats that were susceptible to developing allodynia from minor peripheral nerve
injury.
• In the current experiments, we administered an i.t. injection to female rats to test
whether dexpramipexole can act directly on spinal glia and spinal immune cells to
reverse allodynia.
• In a parallel experiment, to test the possible anti-inflammatory effect of
dexpramipexole on peripheral immune cells, cells were collected from the spleen
because these cells include a large population of T cells.
• In vitro manipulation of splenocytes with an immune stimulator was performed to
determine if co-treatment with dexpramipexole could elevate mRNA levels of IL-10
while simultaneously decreasing IFNγ mRNA levels.

Behavioral Analysis
Hindpaw withdrawal responses to light touch were assessed using the von
Frey fiber test. Behavior was assessed at baseline (BL) and days 3 and
10 or 11 following CCI surgery for all groups. Rats were reassessed for
light touch hindpaw response at 30, 60, and 90 minutes after the injection.
Raw behavioral responses were then entered into the software computer
program, PsychoFit (L. Harvey, University of Colorado), to acquire a 50%
paw withdrawal threshold response rate, and finally, the data were plotted
using GraphPad Prism.
Spleen cell collection
Cells were plated 0.4 million/per well in a 24 well tissue culture plate. Cells
were stimulated for 24 hr with lipopolysaccharide (LPS; 1ug/ml) and
dexpramipexole at 2ug/ml

Day 3
P=0.0001
Figure 1: Intrathecal dexpramipexole does not significantly reverse allodynia. Following CCI, female saccharin (SAC) rats develop a weak ipsilateral
allodynia that persists through day 10 or 11. Rats with prenatal alcohol exposure (PAE) develop a much greater ipsilateral allodynia compared to SAC
rats, with allodynia persisting through day 10 or 11. In both cases allodynia is not significantly reversed by i.t. dexpramipexole. Both PAE and SAC fail
to develop contralateral allodynia, as predicted.

Dexpramipexole effect on inflammatory cytokines in cells from female rats

RNA Extraction and Real-Time PCR
RNeasy Micro Kit (Qiagen) was used to process tissues for total RNA
extraction from spleenocyte cell culture. The concentration and purity of
RNA were then assessed using Quibit (Invitrogen) technology. The initial
concentration of each sample varied to reach a minimum concentration of
2ng/ul. Reverse transcription to obtain cDNA was performed, and for the
endogenous controls, was diluted 1:50, while the target genes Il-10 and
IFNγ were undiluted. The target genes were measured in real time with a
polymerase chain reaction (qRT-PCR) with Taqman Gene Expression
Assays (ThermoFisher Scientific)
Two-way Anova Test
Result where analyzed for statistical significance with a two-way ANOVA
test. In the case of the behavioral results, the independent variables
where Sac vs. PAE and Sham vs. CCI. We preformed one test per time
period (BL, day 3, 10 or 11 after surgery, and 30, 60, and 90 minutes after
injection. In the case of the polymerase chain reaction our variables were
alcohol exposure. (saccrine or prenatal alcohol exposure)

LPS+Dexprami
P<0.0001

Conclusions

Hypothesis
Direct i.t. injection of dexpramapixole will reduce allodynia in female rats and
increase IL-10 mRNA while decreasing IFN mRNA levels from splenocytes.

Our female rat model of PAE and neuropathic pain shows that damage to
the sciatic nerve results in clear susceptibility to developing neuropathic
pain (allodynia). Furthermore, peripheral immune cells such as
splenocytes (consisting predominantly of T cells) from PAE rat offspring
reveal a blunted anti-inflammatory response. In terms of the
effectiveness of dexpramipexole, we can see that PAE offspring do not
show significant reversal of allodynia after an i.t. injection. This could be
because the dose used was too low, and larger doses may be required to
reverse allodynia in these female rats. On the other hand, data from cell
culture qRT-PCR suggest that immune cells from PAE rats reveal a
blunted anti-inflammatory response to dexpramipexole treatment, while
immune cells from Sac controls robustly produce IL-10 in response to
dexpramiexole. In splenocytes from either Sac or PAE rats,
dexpramipexole did not significantly alter the proinflammatory T cell
cytokine, IFNγ.

Methods
Development of Sac and PAE rats:
Rat dams were provided Sac-sweetened alcohol (5%) or Sac-sweetened water for 4
hours/day during gestation (BECs: ~60 mg/dl).
Habituation and Chronic Constriction Injury (CCI).
Long-Evans Rats were housed in the colony room for 4 months prior to the initiation
of experiments. They were then habituated for a week for an hour a day. Chronic
constriction injury (CCI) model is a rat model of neuropathic pain based on a unilateral
loose ligation of the sciatic nerve. Chronic constriction injury consisted of a single
loose ligation of the left sciatic nerve using (4-0).
Intrathecal (i.t.) injection
Lightly anesthetized rats received a single i.t. injection via acute subarachnoid
puncture with drug delivered via a sterile PE-10 tubing threaded 3 cm rostrally to the
spinal cord L5/L6 level. Injections occurred on Day 10/11 post-surgery. Immediately
following drug administration, tubing is removed, and rats are allowed to recover
before being placed in their home cage. All rats recovered within 5 min of drug
administration and resumed normal locomotor function prior to being placed back into
their home cages.

Methods

Figure 2: Dexpramipexol induces greater production of IL-10 when
stimulated with LPS in splenocytes from SAC treated rats but not in
cells from PAE rats. Prenatal alcohol treated offspring reveal blunted
IL-10 production from dexpramipexole with LPS stimulated compared
SAC controls. These data suggest that spinal application of
dexpramipexole fails to elevate IL-10 levels to achieve reversal from
allodynia in females.

Figure 3: Dexpramipexol does not significantly reduce
IFNγ mRNA in splenocytes from Sac rats nor from
splenocytes from PAE when stimulated with LPS.
Prenatal alcohol treated offspring
did not reveal
statistically significant difference in the production of IFNγ
when treated with dexprampipexole.

Reference
Noor, S., Sun, M. S., Vanderwall, A. G., Havard, M. A., Sanchez, J. E., Harris, N. W., . . . Milligan, E. D. (2019).
LFA-1 antagonist (BIRT377) similarly reverses peripheral neuropathic pain in male and female
mice with underlying sex divergent peripheral immune proinflammatory
phenotypes. Neuroimmunology and Neuroinflammation, 2019.doi:10.20517/2347-8659.2019.18
Sanchez, J. J., Noor, S., Davies, S., Savage, D., & Milligan, E. D. (2017). Prenatal alcohol exposure is a
risk factor for adult neuropathic pain via aberrant neuroimmune function. Journal of
Neuroinflammation, 14(1). doi:10.1186/s12974-017-1030-3
Sanchez JJ,* Noor S,* Sun MS, Harris NW, Davies S, Savage DD, Milligan ED. The effects of prenatal alcohol
exposure are life-long: susceptibility to peripheral neuropathy and alterationsin spinal cytokine
actions. Journal of Neuroinflammation, (2017), 14:254. doi:10.1186/s12974-017-1030-3.

Acknowledgment
R01-NIAAA #025967, P50- NIAAA # AA02253

